Chinese COVID vaccine candidate based on inactivated virus appears safe, induces immune response, study finds
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation ...
Nov 18, 2020
0
3